Results 11 to 20 of about 9,743,254 (290)
Cilostazol in patients with heart failure and preserved ejection fraction-The CLIP-HFpEF trial. [PDF]
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Aiad N +9 more
europepmc +2 more sources
Introduction Evidence suggests the presence of deficiencies in the quality of care provided to up to half of all paediatric trauma patients in Canada, the USA and Australia.
Alison Macpherson +23 more
doaj +1 more source
Study objective: To compare the characteristics and outcomes of COVID-19 patients with a hyperdynamic LVEF (HDLVEF) to those with a normal or reduced LVEF. Design: Retrospective study. Setting: Rush University Medical Center.
Annas Rahman +12 more
doaj +1 more source
Clinical outcomes of COVID-19 infection in patients with pre-existing cardiovascular disease
Introduction: Patients with pre-existing cardiovascular disease may carry a higher risk for mortality from COVID-19. This study examined the association between individuals with pre-existing cardiovascular disease admitted for COVID-19 and their clinical
Mina Medhat Kerolos +9 more
doaj +1 more source
The reuse-recycling of objects and materials is a phenomenon frequently identified in ancient constructions. However, despite its apparent banality, archaeologists are not always able to recognize this practice.
Hervé CHOPIN +2 more
doaj +1 more source
Background: Focused transthoracic echocardiography (fTTE) has emerged as a critical diagnostic tool during the COVID-19 pandemic, allowing for efficient cardiac imaging while minimizing staff exposure.
Joanne Michelle D. Gomez +11 more
doaj +1 more source
Study objective: Chest computed tomography (chest CT) is routinely obtained to assess disease severity in COVID-19. While pulmonary findings are well-described in COVID-19, the implications of cardiovascular findings are less well understood.
Maria Isabel Camara Planek +9 more
doaj +1 more source
Impact of pre-existing heart failure on 60-day outcomes in patients hospitalized with COVID-19
Background: In the coronavirus disease 2019 (COVID-19) global pandemic, patients with cardiovascular disease represent a vulnerable population with higher risk for contracting COVID-19 and worse prognosis with higher case fatality rates.
Max Ruge +16 more
doaj +1 more source
Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID‐19
Background Venous thromboembolism (VTE) contributes significantly to COVID‐19 morbidity and mortality. The urokinase receptor system is involved in the regulation of coagulation.
Shengyuan Luo +29 more
doaj +1 more source
Background Persistent atrial fibrillation (AF) is associated with high recurrence rates of AF and atypical atrial flutters or tachycardia (AFT) postablation.
Jamario Skeete +12 more
doaj +1 more source

